Today’s AI Top Pick: PODD

7/14/2026 · Recently Alerted Turnaround screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured daily model accuracy · PODD82%148 resolved forecasts · 45d window · verify →

View the live PODD price forecast →

Today's pick · Recently Alerted TurnaroundPODDBUY NOW8.8 / 107/14/2026

Insulet (PODD) is the cleanest setup on the board today: it passes the turnaround screen (perf 1Y -43.99%, epsNextY +24.37%, recom 1.43) AND the forecast tape confirms across every timeframe. The 4h forecast lays out +14.05% mid / +50.78% long, the daily prints +12.41% / +57.38% / +62.49%, and even the weekly agrees at +8.92% / +32.10% / +50.37%. Kronos bullish_prob is 1.0 with near_term_bullish 1.0 — that combination is rare in this pool and the strongest signal I see. Fundamentals underneath the signal are genuinely strong, not just cheap. FwdPe 20.12, PEG 0.75, ROE 23%, profit margin 10.44%, and salesYoY 31.93% — this is a real growth compounder that has been beaten down 43.99% YTD, not a low-quality bounce. Institutional ownership is 105% (funds crowding back in), recom sits at 1.43 with 44.2% target upside, and fundamental_score is 8. Compare to FUTU (fresh DOJ probe + class actions — landmine), ORCL (14-month low, $300B OpenAI deal called a liability, RSI 26.9 = falling knife), TMDX (analyst PT cut), and JBI (sell-side pan) — PODD's news flow is actually positive today (Insulet/Calm mindfulness partnership, blood glucose monitoring TAM story). The honest pushback is that daily position_in_21bar_range_pct sits at 90.51 — it's not deeply pulled back on the near view. But the 1wk drawdown of -34.28% from the 21-bar high tells you the bigger-picture reset already happened; today's price ($162.06) is early in a turn, not late. The 1h fc_short is -6.05%, which gives you a plausible intraday dip to buy into rather than chasing. Why today: the multi-timeframe stack is aligned right now, the weekly forecast (typically the noisiest) confirms at +50.37% long, and there's no adverse catalyst in the headline flow. Waiting risks losing the setup if the 4h fc_long +50.78% starts to materialize.

PODD forecast chart
Entry zone
$158–$162 (scale in; use the 1h fc_short -6% dip toward $155 as a bonus add zone)
Stop loss
$149 (below 1wk drawdown floor; ~8% risk from mid-entry)
First target
$182 (≈+12%, aligns with 1d fc_short +12.41%)
Longer target
$220–$240 (aligns with 1d fc_mid/long +57%/+62% and 1wk fc_long +50%)
Risks
  • Daily position_in_21bar_range_pct is 90.51% — near-term chase risk; 1h fc_short -6.05% suggests a pullback is likely first
  • Debt/Equity 0.73 and profit margin only 10.44% — leverage plus operating dependence on Omnipod 5 execution
  • Short float 7.04% is moderate but real; a GLP-1 headline (Ozempic/Wegovy adoption) can hit diabetes device names hard
  • Sector rotation risk — 'Insulet Fell Along with Broad Medtech Sector' headline (Jul 13) shows correlation to medtech beta
  • PE 37.72 leaves no room for a guide-down; next earnings is a binary event
Honorable mentions
CELHDaily fc +39.81%/+58.54%/+57.65% with position_in_21bar_range only 33.4% (unextended entry), salesYoY 123.34%, fwdPe 14.94, recom 1.36, and 20.47% short float = squeeze fuel. Held back to #2 by thin 3.68% profit margin and 1wk drawdown -44%.
HSAIBest entry position on the board — 1d pos 14.6%, 4h pos 4.94% — with 1d forecasts +18.8/+48.8/+49.6 and 4h +23.5/+46.4/+45.0. PEG 0.41, targetUpsidePct 98.5%. Docked for China ADR risk, PE 270, and softer 1wk forecast.
Full ranking (30)
#SymbolVerdictScoreRead
1PODDBUY NOW8.8Multi-TF alignment, strong fundamentals (roe 23, fwdPe 20, salesYoY 32), positive Calm partnership news, 1d fc +57%/+62%.
2CELHBUY NOW8.31d fc +58%, pos 33% (great entry), salesYoY 123%, short float 20% squeeze setup.
3HSAIBUY NOW8.1Deep in range (pos 5-15%) with 1d/4h fc +45–50%; PEG 0.41 and 98.5% target upside.
4TIGRBUY NOW8.0Cheapest fwdPe 5.87, roe 14.8, 1d fc +55/+93/+105; China ADR regulatory overhang caps score.
5CALXBUY PULLBACK7.41d fc +26.5%/+31.4%, pos 100% on 1d — wait for the 1h fc_short -3.3% dip before adding.
6SRADBUY PULLBACK7.21d fc +26/+31, PEG 0.48, recom 1.36, but 1h and 1wk forecasts are negative — needs a base.
7MLCOBUY NOW7.0PEG 0.23, 1wk fc +38/+46, pos 9% on weekly; Morgan Stanley downgrade already digested.
8TMDXBUY PULLBACK6.81d fc +55/+63 and 4h +45, but recent Evercore PT cut and 23.57% short float demand patience.
9STEPBUY NOW6.81d fc +29.5/+29.2, recom 1.38, BMO/Barclays maintain positive ratings despite PT trims.
10KKRBUY PULLBACK6.7Fundamentally solid (fwdPe 13.2, recom 1.48) but pos 85–95% and BMO just cut target — chase risk.
11TOSTBUY PULLBACK6.5Goldman upgrade + 1d pos 77%; RSI 67.7 is stretched and long-horizon 1h fc -9.8%.
12SPOTBUY PULLBACK6.41d fc +19/+29 but 1wk fc -9.7/-21/-25 diverges hard — wait for weekly to reset.
13CHWYBUY PULLBACK6.31d fc +44/+58 and roe 63.8, but near_term_bullish only 0.4 and 1h pos at 0.
14PGYWAIT6.2Fundamental_score 8 and recom 1.0, but 1wk fc -19/-37/-42 is a red flag after +57% recent run.
15NOWBUY PULLBACK6.21d fc +20/+28, positive AI target news, but recom 1.32 already priced; wait for pullback below $100.
16SEWAIT6.0RSI 72.9, pos 94% on 1d, 1h/4h fc negative — extended, don't chase.
17HLIBUY PULLBACK5.91d fc +28.5 and pos only 5.5% — good entry, but recom 2.0 (weakest support) and just got PT cut.
18ONONWAIT5.7near_term_bullish 0.2, 1wk fc negative -8/-5; growth story intact but tape not confirming.
19YMMBUY PULLBACK5.6Fundamental_score 8, positive SA upgrade, but expected_return only 15.6% — thesis is late.
20CTGOBUY PULLBACK5.5Gold/silver leverage story with 1d/4h fc +24–45, but no fundamentals block and 1wk down 46%.
21ARESWAIT5.31wk fc -6/-5, near_term_bullish 0.4, debtEq 3.51 — wait for a real base.
22RBBNBUY PULLBACK5.21d/1wk long fc +30/+45 but salesYoY -1.15% and 1d pos 27% needs confirmation.
23WINGWAIT5.01wk drawdown -53%, 4h fc_short flat; BTIG buy call not enough vs. deteriorating trend.
24JBIAVOID4.6Explicit 'sell JBI' StockStory piece and salesYoY -2.54% — thesis broken.
25MIRWAIT4.5PE 171, roe 1.5, short float 14.9%, no recent positive catalyst.
26BESSAVOID4.4Micro-cap $27M, roe -30.7, no revenue disclosed, forecasts unreliable.
27SDAAVOID4.2Micro-cap $84M, PE 458, profitMargin 0.04%, -59% YTD; forecast optically huge but base is tiny.
28GOTUAVOID4.0Profit margin -6.41%, roe -25.79%, epsNextY 1145% is a low-base artifact — no signal here.
29ORCLAVOID3.914-month low, RSI 26.9, retail calling $300B OpenAI deal a 'liability' — falling knife despite huge fc.
30FUTUAVOID3.5Fresh DOJ probe + US class actions (Jul 3) — landmine regardless of the 1d fc +59%.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.